Annual report pursuant to Section 13 and 15(d)

Significant Accounting Policies - Additional Information (Detail)

v3.8.0.1
Significant Accounting Policies - Additional Information (Detail) - USD ($)
12 Months Ended
May 21, 2015
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Apr. 10, 2015
Summary Of Significant Accounting Policies [Line Items]          
Research and development expense, total   $ 33,230,668 $ 32,832,677 $ 18,825,041  
Antidilutive securities excluded from computation of earnings per share, amount   7,324,400 6,975,651 4,994,425  
Employee Stock Purchase Plan [Member]          
Summary Of Significant Accounting Policies [Line Items]          
Common stock, capital shares reserved for future issuance         600,000
Common stock purchase price discount percentage 15.00%